BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

939 related articles for article (PubMed ID: 19442937)

  • 1. Echocardiographic phase imaging to predict reverse remodeling after cardiac resynchronization therapy.
    Buss SJ; Humpert PM; Bekeredjian R; Hardt SE; Zugck C; Schellberg D; Bauer A; Filusch A; Kuecherer H; Katus HA; Korosoglou G
    JACC Cardiovasc Imaging; 2009 May; 2(5):535-43. PubMed ID: 19442937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue synchronisation imaging accurately measures left ventricular dyssynchrony and predicts response to cardiac resynchronisation therapy.
    Van de Veire NR; Bleeker GB; De Sutter J; Ypenburg C; Holman ER; van der Wall EE; Schalij MJ; Bax JJ
    Heart; 2007 Sep; 93(9):1034-9. PubMed ID: 17309912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of cardiac contractility modulation on left ventricular global and regional function and remodeling.
    Yu CM; Chan JY; Zhang Q; Yip GW; Lam YY; Chan A; Burkhoff D; Lee PW; Fung JW
    JACC Cardiovasc Imaging; 2009 Dec; 2(12):1341-9. PubMed ID: 20083066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectral pulsed-wave tissue Doppler imaging lateral-to-septal delay fails to predict clinical or echocardiographic outcome after cardiac resynchronization therapy.
    Soliman OI; Theuns DA; Geleijnse ML; Anwar AM; Nemes A; Caliskan K; Vletter WB; Jordaens LJ; Cate FJ
    Europace; 2007 Feb; 9(2):113-8. PubMed ID: 17218390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of tissue Doppler velocity and strain dyssynchrony for predicting left ventricular reverse remodeling response after cardiac resynchronization therapy.
    Yu CM; Gorcsan J; Bleeker GB; Zhang Q; Schalij MJ; Suffoletto MS; Fung JW; Schwartzman D; Chan YS; Tanabe M; Bax JJ
    Am J Cardiol; 2007 Oct; 100(8):1263-70. PubMed ID: 17920368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triplane tissue Doppler imaging: a novel three-dimensional imaging modality that predicts reverse left ventricular remodelling after cardiac resynchronisation therapy.
    Van de Veire NR; Yu CM; Ajmone-Marsan N; Bleeker GB; Ypenburg C; De Sutter J; Zhang Q; Fung JW; Chan JY; Holman ER; van der Wall EE; Schalij MJ; Bax JJ
    Heart; 2008 Mar; 94(3):e9. PubMed ID: 17984218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy.
    Bax JJ; Bleeker GB; Marwick TH; Molhoek SG; Boersma E; Steendijk P; van der Wall EE; Schalij MJ
    J Am Coll Cardiol; 2004 Nov; 44(9):1834-40. PubMed ID: 15519016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of echocardiographic dyssynchrony in patients with borderline QRS duration to assist with selection for cardiac resynchronization therapy.
    Oyenuga O; Hara H; Tanaka H; Kim HN; Adelstein EC; Saba S; Gorcsan J
    JACC Cardiovasc Imaging; 2010 Feb; 3(2):132-40. PubMed ID: 20159638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative gated SPECT-derived phase analysis on gated myocardial perfusion SPECT detects left ventricular dyssynchrony and predicts response to cardiac resynchronization therapy.
    Boogers MM; Van Kriekinge SD; Henneman MM; Ypenburg C; Van Bommel RJ; Boersma E; Dibbets-Schneider P; Stokkel MP; Schalij MJ; Berman DS; Germano G; Bax JJ
    J Nucl Med; 2009 May; 50(5):718-25. PubMed ID: 19403876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive parameters of left ventricular reverse remodeling in response to cardiac resynchronization therapy in patients with severe congestive heart failure.
    De Maria E; Gallo P; Damiano M; Scognamiglio G; De Simone C; Nilo S; Guarini P; Mascioli G; Curnis A
    Ital Heart J; 2005 Sep; 6(9):734-9. PubMed ID: 16212075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of intraventricular mechanical dyssynchrony and prediction of response to cardiac resynchronization therapy: comparison between tissue Doppler imaging and real-time three-dimensional echocardiography.
    Kleijn SA; van Dijk J; de Cock CC; Allaart CP; van Rossum AC; Kamp O
    J Am Soc Echocardiogr; 2009 Sep; 22(9):1047-54. PubMed ID: 19647409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel tool to assess systolic asynchrony and identify responders of cardiac resynchronization therapy by tissue synchronization imaging.
    Yu CM; Zhang Q; Fung JW; Chan HC; Chan YS; Yip GW; Kong SL; Lin H; Zhang Y; Sanderson JE
    J Am Coll Cardiol; 2005 Mar; 45(5):677-84. PubMed ID: 15734610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of extensive LV remodeling limits the benefits of CRT in patients with intraventricular dyssynchrony.
    Carluccio E; Biagioli P; Alunni G; Murrone A; Pantano P; Biscottini E; Zuchi C; Zingarini G; Cavallini C; Ambrosio G
    JACC Cardiovasc Imaging; 2011 Oct; 4(10):1067-76. PubMed ID: 21999865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Echocardiographic patient selection for cardiac resynchronization therapy: betting on a dead horse?
    Breithardt OA
    JACC Cardiovasc Imaging; 2009 May; 2(5):544-7. PubMed ID: 19442938
    [No Abstract]   [Full Text] [Related]  

  • 15. Longitudinal two-dimensional strain rate imaging: a potential approach to predict the response to cardiac resynchronization therapy.
    Shi H; Shu X; Wang F; Cui J; Chen H; Sun B; Liu S
    Int J Cardiovasc Imaging; 2009 Oct; 25(7):677-87. PubMed ID: 19639392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of left ventricular systolic dyssynchrony by real-time three-dimensional echocardiography to predict long-term response to cardiac resynchronization therapy.
    Soliman OI; Geleijnse ML; Theuns DA; van Dalen BM; Vletter WB; Jordaens LJ; Metawei AK; Al-Amin AM; ten Cate FJ
    Am J Cardiol; 2009 Jun; 103(11):1586-91. PubMed ID: 19463520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline aortic pre-ejection interval predicts reverse remodeling and clinical improvement after cardiac resynchronization therapy.
    Aksoy H; Okutucu S; Aytemir K; Kaya EB; Evranos B; Kabakci G; Tokgozoglu L; Ozkutlu H; Oto A
    Cardiol J; 2011; 18(6):639-47. PubMed ID: 22113751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac resynchronization therapy in patients with systolic left ventricular dysfunction and symptoms of mild heart failure secondary to ischemic or nonischemic cardiomyopathy.
    Bleeker GB; Schalij MJ; Holman ER; Steendijk P; van der Wall EE; Bax JJ
    Am J Cardiol; 2006 Jul; 98(2):230-5. PubMed ID: 16828599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left ventricular resynchronization is mandatory for response to cardiac resynchronization therapy: analysis in patients with echocardiographic evidence of left ventricular dyssynchrony at baseline.
    Bleeker GB; Mollema SA; Holman ER; Van de Veire N; Ypenburg C; Boersma E; van der Wall EE; Schalij MJ; Bax JJ
    Circulation; 2007 Sep; 116(13):1440-8. PubMed ID: 17785624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Additional value of three-dimensional echocardiography in patients with cardiac resynchronization therapy.
    Deplagne A; Bordachar P; Reant P; Montaudon M; Reuter S; Laborderie J; Dos Santos P; Roudaut R; Jais P; Haissaguerre M; Laurent F; Clementy J; Lafitte S
    Arch Cardiovasc Dis; 2009; 102(6-7):497-508. PubMed ID: 19664569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.